Waters, James (2011): The effect of the Sarbanes-Oxley Act on innovation.
Download (628Kb) | Preview
This paper adds to the literature on the Sarbanes-Oxley Act's net effects by looking at whether its passage was associated with a change in innovation and patenting. Its effects are separated into temporary uncertainty and changes in long term investment incentives in a dynamic programming problem faced by innovators who learn over time about SOX's effect. Innovation is found to fall under uncertainty for potential losses that are low relative to the potential profits. As companies learn, innovation rates readjust to SOX's long term persistent effect. We examine US patenting in stem cell technologies from 2001 to 2009 for SOX related changes. To reduce the dependence of our estimates on timing assumptions, we look for changes over the whole period. We firstly use a rolling break test with a single break point with Monte Carlo correction to p-values for search process endogeneity and MLE bias. Secondly, we run a hidden Markov model allowing for multiple states in the patent process and transitions between the states. We find a large and statistically significant change at a date consistent with a SOX effect under both testing methods. A three state hidden Markov model finds subsequent correction consistent with the theoretical model. Four competing explanations are found to account incompletely for the observed data.
|Item Type:||MPRA Paper|
|Original Title:||The effect of the Sarbanes-Oxley Act on innovation|
|Keywords:||Sarbanes-Oxley; investment; innovation; patents|
|Subjects:||K - Law and Economics > K2 - Regulation and Business Law
O - Economic Development, Technological Change, and Growth > O3 - Technological Change; Research and Development; Intellectual Property Rights > O31 - Innovation and Invention: Processes and Incentives
D - Microeconomics > D9 - Intertemporal Choice and Growth > D92 - Intertemporal Firm Choice and Growth, Financing, Investment, and Capacity
|Depositing User:||James Waters|
|Date Deposited:||12. Jan 2011 21:11|
|Last Modified:||13. Feb 2013 02:14|
Ashbaugh-Skaife, H., Collins, D., Kinney, W. and LaFond, R. (2009) The Effect of SOX Internal Control Deficiencies on Firm Risk and Cost of Equity, Journal of Accounting Research, 47, 1-43.
Bargeron, L., Lehn, K. and Zutter, C. (2010) Sarbanes-Oxley and Corporate Risk-Taking, Journal of Accounting and Economics, 49, 34-52.
Blazsek, S. and Escribano, A. (2010) Knowledge spillovers in US patents: A dynamic patent intensity model with secret common innovation factors, Journal of Econometrics, 159, 14-32.
Bloom, N. (2009) The Impact of Uncertainty Shocks, Econometrica, 77, 623-85.
Blundell, R., Griffith, R. and Van Reenen, J. (1995) Dynamic Count Data Models of Technological Innovation, Economic Journal, 105, 333-44.
Blundell, R., Griffith, R. and Windmeijer, F. (2002) Individual effects and dynamics in count data models, Journal of Econometrics, 108, 113-31.
Chhaochharia, V. and Grinstein, Y. (2007) Corporate Governance and Firm Value: The Impact of the 2002 Governance Rules, Journal of Finance, 62, 1789-825.
Doidge, C., Karolyi, A. and Stulz, R. (2009) Has New York become less competitive in global markets? Evaluating foreign listing choices over time, Journal of Financial Economics, 91, 253-77.
Engel, E., Hayes, R. and Wang, X. (2007) The Sarbanes-Oxley Act and Firms' Going Private Decisions, Journal of Accounting and Economics, 44, 116-45.
Gao, F., Wu, J. and Zimmerman, J. (2009) Unintended Consequences of Granting Small Firms Exemptions from Securities Regulation: Evidence from the Sarbanes-Oxley Act, Journal of Accounting Research, 47, 459-506.
Guo, X., Miao, J. and Morellec, E. (2005) Irreversible investment with regime shifts, Journal of Economic Theory, 122, 37-59.
Gurmu, S. and Perez-Sebastian, F. (2008) Patents, R&D and lag effects: evidence from flexible methods for count panel data on manufacturing firms, Empirical Economics, 35, 507-26.
Hall, B., Griliches, Z. and Hausman, J. (1986) Patents and R and D: Is There A Lag?, International Economic Review, 27, 265-83.
Hamilton, J. (1994) Time Series Analysis, Princeton University Press: Princeton.
Hartman, T. (2007) The cost of being public in the era of Sarbanes-Oxley, Tech. rep., Foley & Lardner LLP.
Jain, P., Kim, J.-C. and Rezaee, Z. (2008) The Sarbanes-Oxley Act of 2002 and Market Liquidity, The Financial Review, 43, 361-82.
Kamar, E., Karaca-Mandic, P. and Talley, E. (2007) Sarbanes-Oxley's Effects on Small Firms: What is the Evidence?, USC CLEO Research Paper C07-9, University of Southern California Law School.
Kang, Q., Liu, Q. and Qi, R. (2010) The Sarbanes-Oxley Act and Corporate Investment: A Structural Assessment, Journal of Financial Economics, 96, 291-305.
Leuz, C., Triantis, A. andWang, T. (2008) Why Do Firms Go Dark? Causes and Economic Consequences of Voluntary SEC Deregistrations, Journal of Accounting and Economics, 45, 181-208.
Li, H., Pincus, M. and Rego, S. (2008) Market Reaction to Events Surrounding the Sarbanes-Oxley Act of 2002 and Earnings Management, Journal of Law and Economics, 51, 111-34.
Linck, J., Netter, J. and Yang, T. (2009) The Effects and Unintended Consequences of the Sarbanes-Oxley Act on the Supply and Demand for Directors, Review of Financial Studies, 22, 3287-328.
Litvak, K. (2007) Sarbanes-Oxley and the Cross-Listing Premium, Michigan Law Review, 105, 1857-98.
Lysaght, M., Jaklenec, A. and Deweerd, E. (2008) Great Expectations: Private Sector Activity in Tissue Engineering, Regenerative Medicine, and Stem Cell Therapeutics, Tissue Engineering: Part A, 14, 305-15.
Montalvo, J. (1997) GMM Estimation of Count-Panel-Data Models With Fixed Eects and Predetermined Instruments, Journal of Business and Economic Statistics, 15, 82-9.
R Development Core Team (2009) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, http://www.R-project.org.
Salter, B. (2005) The global politics of human embryonic stem cell science, Global Biopolitics Research Group Working Paper 2, University of East Anglia.
Sarbanes-Oxley (2002) Sarbanes-Oxley Act of 2002, Public Law 107-204, 107th Cong., 30 July 2002.
United States White House (2001) Embryonic Stem Cell Research. White House Fact Sheet, downloaded from http://georgewbush-whitehouse.archives.gov/news/releases/2001/08/20010809-1.html.
USPTO (2010) USPTO Patent Full-Text and Image Database, downloaded from http://patft.uspto.gov/.
Wintoki, M. (2007) Corporate Boards and Regulation: The Effect of the Sarbanes-Oxley Act and the Exchange Listing Requirements on Firm Value, Journal of Corporate Finance, 13, 229-50.
Zhang, I. (2007) Economic consequences of the Sarbanes-Oxley Act of 2002, Journal of Accounting and Economics, 44, 74-115.
Zucchini, W. and MacDonald, I. (2009) Hidden Markov Models for Time Series: An Introduction Using R, CRC Press: Florida.